Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,837
Closed -$260K 29
2017
Q4
$260K Sell
4,837
-58
-1% -$3.21K 0.19% 29
2017
Q3
$299K Buy
4,895
+1
+0% +$61 0.21% 32
2017
Q2
$299K Sell
4,894
-31
-0.6% -$1.89K 0.22% 31
2017
Q1
$298K Sell
4,925
-1,340
-21% -$81.3K 0.23% 32
2016
Q4
$352K Buy
6,265
+2
+0% +$117 0.28% 31
2016
Q3
$372K Buy
6,263
+3
+0% +$175 0.33% 27
2016
Q2
$344K Sell
6,260
-57
-0.9% -$3.03K 0.29% 29
2016
Q1
$318K Buy
6,317
+2
+0% +$98 0.27% 30
2015
Q4
$318K Buy
6,315
+3
+0% +$151 0.26% 30
2015
Q3
$297K Sell
6,312
-58
-0.9% -$3.08K 0.21% 31
2015
Q2
$346K Sell
6,370
-240
-4% -$13.5K 0.2% 30
2015
Q1
$362K Sell
6,610
-405
-6% -$22.9K 0.19% 31
2014
Q4
$380K Sell
7,015
-1,469
-17% -$81.8K 0.19% 32
2014
Q3
$479K Sell
8,484
-58
-0.7% -$3.26K 0.25% 33
2014
Q2
$471K Buy
+8,542
New +$466K 0.22% 32

Other funds holding MRK

ValueWorks's MRK Position: Q1 2018 in Review

ValueWorks sold out of Merck (MRK) in Q1 2018, closing a stake of 4,837 shares — an estimated $260K sold.

ValueWorks first reported a position in MRK in Q2 2014 and held it in 15 quarters. The position peaked at $479K in Q3 2014. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • ValueWorks reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
  • ValueWorks sold 4,837 Merck shares in Q1 2018, an estimated $260K.
  • ValueWorks first reported a position in Merck in Q2 2014 and held it in 15 quarters.
  • ValueWorks's Merck position peaked at $479K in Q3 2014.
  • 1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on ValueWorks's 13F filing for Q1 2018, filed 17 May 2018.